NCT06089161 Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
| NCT ID | NCT06089161 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 330 participants |
| Start Date | 2024-03-19 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 330 participants in total. It began in 2024-03-19 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
Eligibility Criteria
Inclusion Criteria: * Self-reported race/ethnicity as African American, African, Caribbean or black * Ages 60-85 years * accessible by phone * OSA diagnosis * consent, including permission to release medical data Exclusion Criteria: * progressive illnesses in which disability or death is expected within 1 year * impaired cognitive/ functional ability precluding participation * intention to move within the year * and a family member currently enrolled.
Contact & Investigator
Girardin Jean-Louis, PhD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT06089161 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 85 Years, studying Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06089161 currently recruiting?
Yes, NCT06089161 is actively recruiting participants. Contact the research team at girardin.jean-louis@miami.edu for enrollment information.
Where is the NCT06089161 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06089161 clinical trial?
NCT06089161 is sponsored by University of Miami. The principal investigator is Girardin Jean-Louis, PhD at University of Miami. The trial plans to enroll 330 participants.